FDA Inspection 1209293 — Hong Jang-Hee, MD, PhD
The FDA completed an inspection of Hong Jang-Hee, MD, PhD on June 23, 2023 in Jung District. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 23, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Jung District (Korea (the Republic of))
Additional Details
Clinical BA/BE